AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30500309 — intervention group
Group type: COMPARATOR
Intervention: Contact matched control condition
Number of subjects: 50
Study 28182243 — intervention group
Group type: EXPERIMENTAL
Intervention: Cut‐down‐to‐quit (CDTQ)
Number of subjects: 1077
Study 28182243 — intervention group
Group type: COMPARATOR
Intervention: Quit immediately (QI)
Number of subjects: 1077
Study 25522265 — intervention group
Group type: EXPERIMENTAL
Intervention: Broccoli sprouts (200 μmol SFN daily)
Number of subjects: 0
Study 25522265 — intervention group
Group type: COMPARATOR
Intervention: Myrosinase-treated broccoli sprout extract (BSE) (200 μmol SFN daily)
Number of subjects: 0
Study 25522265 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice daily dosing (two 100-μmol doses taken 12 h apart)
Number of subjects: 0
Study 25522265 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose (200 μmol SFN)
Number of subjects: 0
Study 23575739 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine
Number of subjects: 11
Study 23575739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 23575739 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 11
Study 23575739 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart failure patients
Number of subjects: 11
Study 20929915 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ferric carboxymaltose 1000 mg over 15 min (with up to two additional doses of 500 mg at 2-week intervals)
Number of subjects: 255
Study 20929915 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ferric carboxymaltose 1000 mg over 15 min
Number of subjects: 255
Study 20929915 — intervention group
Group type: COMPARATOR
Intervention: Oral ferrous sulphate 325 mg thrice daily for a total of 195 mg elemental iron daily for 56 days
Number of subjects: 255
Study 20929915 — intervention group
Group type: COMPARATOR
Intervention: Oral ferrous sulphate
Number of subjects: 255
Study 20929915 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ferric carboxymaltose
Number of subjects: 255
Study 19829198 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care intervention
Number of subjects: 232
Study 19829198 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 232
Study 18236203 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week treatment group (n = 10)
Number of subjects: 34
Study 18236203 — intervention group
Group type: COMPARATOR
Intervention: no-intervention group (n = 15)
Number of subjects: 34
Study 15015440 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative Chinese and Western medicine (ICWM)
Number of subjects: 60
Study 15015440 — intervention group
Group type: COMPARATOR
Intervention: Conventional western medicine alone
Number of subjects: 60
Study 11685409 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual-only series
Number of subjects: 6
Study 11685409 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual-vestibular series (0.8 Hz)
Number of subjects: 6
Study 11685409 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual-vestibular series (0.1 Hz)
Number of subjects: 6
Study 11685409 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual-vestibular- neck series
Number of subjects: 6
Study 11685409 — intervention group
Group type: EXPERIMENTAL
Intervention: Targets presented at SSA
Number of subjects: 6
Study 9532649 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascolong (12.5 mg) administered once or regularly for 2 weeks
Number of subjects: 62
Study 9532649 — intervention group
Group type: COMPARATOR
Intervention: Ascolong (12.5 mg)
Number of subjects: 62
Study 8057111 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose levodopa-carbidopa (<= 600/150 mg/day)
Number of subjects: 149
Study 8057111 — intervention group
Group type: COMPARATOR
Intervention: Low dose bromocriptine (<= 30 mg/day)
Number of subjects: 149
Study 8057111 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa-carbidopa (added to bromocriptine)
Number of subjects: 149
Study 2970159 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% clindamycin phosphate in alcoholic solution
Number of subjects: 60
Study 2970159 — intervention group
Group type: COMPARATOR
Intervention: 5% benzoyl peroxide gel
Number of subjects: 60
Study 29126209 — intervention group
Group type: EXPERIMENTAL
Intervention: SmokeBeat app for 30 days
Number of subjects: 40
Study 29126209 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 40
Study 28284888 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention and sleep hygiene
Number of subjects: 125
Study 28284888 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 125
Study 26699542 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese Herbal Medicine (CHM)
Number of subjects: 1960
Study 26699542 — intervention group
Group type: COMPARATOR
Intervention: Non-Chinese Herbal Medicine (non-CHM)
Number of subjects: 1960
Study 23152361 — intervention group
Group type: EXPERIMENTAL
Intervention: Irsogladine maleate (IM) 4 mg/day for 14 days
Number of subjects: 66
Study 23152361 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 19189989 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture and auricular acupressure (n = 21)
Number of subjects: 46
Study 19189989 — intervention group
Group type: COMPARATOR
Intervention: Hormone replacement therapy (HRT) - Tibolone (n = 25)
Number of subjects: 46
Study 19189989 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 46
Study 18165043 — intervention group
Group type: EXPERIMENTAL
Intervention: Midvastus approach
Number of subjects: 20
Study 18165043 — intervention group
Group type: COMPARATOR
Intervention: Median parapatellar approach
Number of subjects: 20
Study 16676251 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularization and replantation
Number of subjects: 12
Study 16676251 — intervention group
Group type: COMPARATOR
Intervention: Amputation
Number of subjects: 12
Study 15120550 — intervention group
Group type: EXPERIMENTAL
Intervention: Reicher-Wheeler task with eye-tracking for word recognition
Number of subjects: 0
Study 15120550 — intervention group
Group type: EXPERIMENTAL
Intervention: Reicher-Wheeler task with eye-tracking for non-word recognition
Number of subjects: 0
Study 10904853 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment according to the etiology of the disease (specific treatment not detailed in the abstract)
Number of subjects: 182
Study 10904853 — intervention group
Group type: COMPARATOR
Intervention: Placebo (not explicitly mentioned but implied as part of the American Myocarditis Treatment Trial)
Number of subjects: 182
Study 9488974 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine for 8 weeks
Number of subjects: 40
Study 9488974 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 40
Study 9488974 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine or didanosine before and after treatment
Number of subjects: 40
Study 7870965 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine administered alone (4-96 mg/70 kg)
Number of subjects: 0
Study 7870965 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol administered alone (0-1.0 g/kg)
Number of subjects: 0
Study 7870965 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine and alcohol combined
Number of subjects: 0
Study 2877683 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide and enflurane
Number of subjects: 20
Study 2877683 — intervention group
Group type: COMPARATOR
Intervention: Narcotic-barbiturate technique
Number of subjects: 20
Study 28639841 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI), a structured eight-week mindfulness-based educational and training programme
Number of subjects: 50
Study 28639841 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 50
Study 28639841 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 50
Study 25887111 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramelteon 8 mg before bedtime for 4 weeks
Number of subjects: 16
Study 25887111 — intervention group
Group type: COMPARATOR
Intervention: Placebo before bedtime for 4 weeks
Number of subjects: 16
Study 24887018 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 night of unrestricted sleep (n=13)
Number of subjects: 26
Study 24887018 — intervention group
Group type: COMPARATOR
Intervention: 1 night of total sleep deprivation (24 hours of wakefulness) (n=13)
Number of subjects: 26
Study 22925428 — intervention group
Group type: EXPERIMENTAL
Intervention: Reimbursement for smoking cessation treatment
Number of subjects: 187
Study 22925428 — intervention group
Group type: COMPARATOR
Intervention: Traditional productivity cost estimates
Number of subjects: 187
Study 22925428 — intervention group
Group type: COMPARATOR
Intervention: Adjusted productivity cost estimates
Number of subjects: 187
Study 22925428 — intervention group
Group type: COMPARATOR
Intervention: Combined impacts of compensation and multiplier effects
Number of subjects: 187
Study 21211458 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin group (n = 23)
Number of subjects: 53
Study 21211458 — intervention group
Group type: EXPERIMENTAL
Intervention: SSC Group (n = 30)
Number of subjects: 53
Study 21211458 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 15)
Number of subjects: 53
Study 18533353 — intervention group
Group type: EXPERIMENTAL
Intervention: Activia yogurt (2 units/day)
Number of subjects: 378
Study 18533353 — intervention group
Group type: COMPARATOR
Intervention: Lacteous dessert without probiotics (control)
Number of subjects: 378
Study 15948996 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral pimecrolimus 30 mg twice daily
Number of subjects: 103
Study 15948996 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral pimecrolimus 20 mg twice daily
Number of subjects: 103
Study 15948996 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral pimecrolimus 10 mg twice daily
Number of subjects: 103
Study 15948996 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study 14632333 — intervention group
Group type: EXPERIMENTAL
Intervention: nCPAP
Number of subjects: 42
Study 14632333 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation
Number of subjects: 42
Study 14632333 — intervention group
Group type: EXPERIMENTAL
Intervention: nCPAP and Conventional ventilation
Number of subjects: 42
Study 10888946 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (frequently repeated active submaximal movements combined with mechanical diagnosis and therapy)
Number of subjects: 97
Study 10888946 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (early administration within 96 hours)
Number of subjects: 97
Study 10888946 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (initial rest, recommended use of a soft collar, gradual self-mobilization)
Number of subjects: 97
Study 8645068 — intervention group
Group type: EXPERIMENTAL
Intervention: Aortography
Number of subjects: 0
Study 8645068 — intervention group
Group type: EXPERIMENTAL
Intervention: Transesophageal echocardiography
Number of subjects: 0
Study 8645068 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic chest computed tomography
Number of subjects: 0
Study 8645068 — intervention group
Group type: COMPARATOR
Intervention: Observation with follow-up chest radiography
Number of subjects: 0
Study 1416808 — intervention group
Group type: COMPARATOR
Intervention: Valproate (VPA), 15 mg/kg
Number of subjects: 44
Study 1416808 — intervention group
Group type: EXPERIMENTAL
Intervention: Felbamate (FBM), 3,600 mg/day
Number of subjects: 44
Study 2992898 — intervention group
Group type: EXPERIMENTAL
Intervention: Active marijuana (2.9% delta 9THC)
Number of subjects: 13
Study 2992898 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.0% delta 9THC)
Number of subjects: 13
Study 29496255 — intervention group
Group type: EXPERIMENTAL
Intervention: Tivantinib (360 mg twice daily) plus Erlotinib (150 mg daily)
Number of subjects: 96
Study 29496255 — intervention group
Group type: COMPARATOR
Intervention: Single-agent chemotherapy (investigator's choice of pemetrexed, docetaxel, or gemcitabine)
Number of subjects: 96
Study 29496255 — intervention group
Group type: COMPARATOR
Intervention: Single-agent chemotherapy (C)
Number of subjects: 96
Study 29496255 — intervention group
Group type: EXPERIMENTAL
Intervention: Tivantinib plus Erlotinib (ET)
Number of subjects: 96
Study 26825266 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-to-Family intervention (FTF)
Number of subjects: 318
Study 26825266 — intervention group
Group type: COMPARATOR
Intervention: Waitlist condition (Control)
Number of subjects: 318
Study 24655901 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine‐gluconate ethanol
Number of subjects: 0
Study 24655901 — intervention group
Group type: COMPARATOR
Intervention: 10% povidone‐iodine
Number of subjects: 0
Study 22997204 — intervention group
Group type: EXPERIMENTAL
Intervention: BNP-driven fluid management strategy
Number of subjects: 304
Study 22997204 — intervention group
Group type: COMPARATOR
Intervention: Physician-driven strategy
Number of subjects: 304
Study 20492438 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-min tongue-task training regime
Number of subjects: 72
Study 20492438 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine tongue-task training regime
Number of subjects: 72
Study 20492438 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin tongue-task training regime
Number of subjects: 72
Study 20492438 — intervention group
Group type: COMPARATOR
Intervention: 15-min tongue-task training regime
Number of subjects: 72
Study 18632218 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral visual inspection intervention
Number of subjects: 96517
Study 18632218 — intervention group
Group type: EXPERIMENTAL
Intervention: Screened individuals
Number of subjects: 96517
Study 18632218 — intervention group
Group type: EXPERIMENTAL
Intervention: Age factor in screening
Number of subjects: 96517
Study 18632218 — intervention group
Group type: EXPERIMENTAL
Intervention: Household size
Number of subjects: 96517
Study 18632218 — intervention group
Group type: EXPERIMENTAL
Intervention: Compliance with referral
Number of subjects: 96517
Study 15978535 — intervention group
Group type: EXPERIMENTAL
Intervention: salbutamol (600 microg)
Number of subjects: 8
Study 15978535 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 8
Study 12192164 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial therapy (various types)
Number of subjects: 25
Study 9524967 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental oxygen (O2) during sedation
Number of subjects: 14
Study 9524967 — intervention group
Group type: COMPARATOR
Intervention: Non-supplemental oxygen (non-O2) during sedation
Number of subjects: 14
Study 9524967 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental oxygen (O2) during postoperative period
Number of subjects: 14
Study 9524967 — intervention group
Group type: COMPARATOR
Intervention: Non-supplemental oxygen (non-O2) during postoperative period
Number of subjects: 14
Study 7924477 — intervention group
Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (DSCG), 40 mg
Number of subjects: 17
Study 7924477 — intervention group
Group type: COMPARATOR
Intervention: No intervention (test A without premidication)
Number of subjects: 17
Study 2451414 — intervention group
Group type: EXPERIMENTAL
Intervention: encainide
Number of subjects: 687
Study 2451414 — intervention group
Group type: EXPERIMENTAL
Intervention: flecainide
Number of subjects: 687
Study 2451414 — intervention group
Group type: EXPERIMENTAL
Intervention: imipramine
Number of subjects: 687
Study 2451414 — intervention group
Group type: EXPERIMENTAL
Intervention: moricizine
Number of subjects: 687
Study 2451414 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 687
Study 31895776 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM) individualized treatment
Number of subjects: 12
Study 31895776 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 29794268 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine with methylprednisolone (LC-group)
Number of subjects: 136
Study 29794268 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine without methylprednisolone (LA-group)
Number of subjects: 136
Study 30135888 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflated education about ultrasound (EG)
Number of subjects: 67
Study 30135888 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra-inflated education about ultrasound (EEG)
Number of subjects: 67
Study 30135888 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 67
Study 25065710 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose computed tomography (LDCT)
Number of subjects: 2812
Study 25065710 — intervention group
Group type: COMPARATOR
Intervention: Chest X-ray (CXR)
Number of subjects: 2812
Study 22220807 — intervention group
Group type: EXPERIMENTAL
Intervention: Scalp psoriasis (SP)
Number of subjects: 42
Study 22220807 — intervention group
Group type: EXPERIMENTAL
Intervention: Seborrheic dermatitis (SD)
Number of subjects: 42
Study 22220807 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy adults)
Number of subjects: 42
Study 21633535 — intervention group
Group type: EXPERIMENTAL
Intervention: Water infusion limited to the rectum, sigmoid colon and descending colon
Number of subjects: 179
Study 21633535 — intervention group
Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 179
Study 20003758 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide treatment
Number of subjects: 11
Study 20003758 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide administration 1 hour before MMTT
Number of subjects: 11
Study 20003758 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrospective analysis of 3-month follow-up
Number of subjects: 11
Study 16738289 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 0.1 mg.kg(‐1) iv
Number of subjects: 40
Study 15537991 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-oriented physical therapy with rehabilitation technology (treadmill, Kinetron isokinetic exerciser, limb-load monitor)
Number of subjects: 63
Study 15537991 — intervention group
Group type: COMPARATOR
Intervention: Task-oriented physical therapy without rehabilitation technology
Number of subjects: 63
Study 15537991 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-oriented physical therapy (both groups pooled)
Number of subjects: 63
Study 11208940 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorogenic acid (2.8 mmol)
Number of subjects: 7
Study 11208940 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeic acid (2.8 mmol)
Number of subjects: 7
Study 10322887 — intervention group
Group type: EXPERIMENTAL
Intervention: Sanhuang Jiangtang recipe (SHJT)
Number of subjects: 95
Study 10322887 — intervention group
Group type: COMPARATOR
Intervention: Glipizide
Number of subjects: 95
Study 8145656 — intervention group
Group type: EXPERIMENTAL
Intervention: Homoeopathic high dilutions of tobacco
Number of subjects: 0
Study 8145656 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6362385 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment (crossover group)
Number of subjects: 311
Study 6362385 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment (medical adherers group)
Number of subjects: 311
Study 6362385 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical nonadherers (crossover group)
Number of subjects: 311
Study 6362385 — intervention group
Group type: COMPARATOR
Intervention: Surgical adherers (surgically randomized patients)
Number of subjects: 311
Study 31697727 — intervention group
Group type: EXPERIMENTAL
Intervention: Noisy galvanic vestibular stimulation (nGVS)
Number of subjects: 28
Study 31697727 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 28
Study 28763575 — intervention group
Group type: EXPERIMENTAL
Intervention: Rupatadine 10 mg
Number of subjects: 27
Study 28763575 — intervention group
Group type: EXPERIMENTAL
Intervention: Rupatadine 20 mg
Number of subjects: 27
Study 28763575 — intervention group
Group type: EXPERIMENTAL
Intervention: Rupatadine 40 mg
Number of subjects: 27
Study 28763575 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 28763575 — intervention group
Group type: EXPERIMENTAL
Intervention: Rupatadine (all doses)
Number of subjects: 27
Study 28763575 — intervention group
Group type: COMPARATOR
Intervention: Comparison with Caucasian subjects
Number of subjects: 27
Study 26964877 — intervention group
Group type: EXPERIMENTAL
Intervention: Shortened, patient-designed informed consent document (5 pages)
Number of subjects: 201
Study 26964877 — intervention group
Group type: EXPERIMENTAL
Intervention: Video informed consent format
Number of subjects: 201
Study 26964877 — intervention group
Group type: COMPARATOR
Intervention: Standard paper informed consent document (17 pages)
Number of subjects: 201
Study 25895304 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon nanoparticles group
Number of subjects: 72
Study 25895304 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 72
Study 22295891 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplement (2 g containing 600 mg EPA and DHA) for 9 weeks
Number of subjects: 23
Study 22295891 — intervention group
Group type: COMPARATOR
Intervention: Nonsupplemented group (NSG)
Number of subjects: 23
Study 20554982 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal antiretroviral regimen
Number of subjects: 2369
Study 20554982 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant nevirapine prophylaxis
Number of subjects: 2369
Study 20554982 — intervention group
Group type: COMPARATOR
Intervention: No extended postnatal antiretroviral regimen (control group)
Number of subjects: 2369
Study 17913001 — intervention group
Group type: EXPERIMENTAL
Intervention: CPC/ZG mucoadhesive gel
Number of subjects: 80
Study 17913001 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 80
Study 17241421 — intervention group
Group type: EXPERIMENTAL
Intervention: UV-B irradiation after BoNT/A injection
Number of subjects: 6
Study 17241421 — intervention group
Group type: COMPARATOR
Intervention: BoNT/A injection (100 mU)
Number of subjects: 6
Study 15058368 — intervention group
Group type: EXPERIMENTAL
Intervention: Gracey mini‐curettes (MiniFive)
Number of subjects: 10